This post is from a suggested group
Understanding Anti-VEGF Therapy: A Breakthrough in Eye and Cancer Treatments
Anti-VEGF (Vascular Endothelial Growth Factor) therapy represents a significant advancement in modern medicine, particularly in treating eye diseases and certain cancers. VEGF is a protein responsible for promoting the growth of new blood vessels, a process known as angiogenesis. While angiogenesis is crucial for normal growth and healing, excessive VEGF activity can lead to harmful conditions, including abnormal blood vessel growth in the eye and tumor vascularization in cancers.
Role in Ophthalmology
One of the most prominent applications of Anti-VEGF therapy is in ophthalmology. Diseases such as age-related macular degeneration (AMD), diabetic retinopathy, and retinal vein occlusion often involve the abnormal growth of blood vessels in the retina. These new vessels are typically fragile and prone to leakage, resulting in vision loss. Anti-VEGF drugs work by inhibiting the action of VEGF, effectively reducing the growth of these abnormal vessels and…